MARKET

ENZ

ENZ

Enzo Biochem Inc
NYSE
1.100
-0.020
-1.79%
Closed 15:35 06/24 EDT
OPEN
1.150
PREV CLOSE
1.120
HIGH
1.150
LOW
1.065
VOLUME
169.60K
TURNOVER
0
52 WEEK HIGH
2.210
52 WEEK LOW
0.9901
MARKET CAP
56.60M
P/E (TTM)
-4.3755
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ENZ last week (0617-0621)?
Weekly Report · 22h ago
Enzo Biochem Third Quarter 2024 Earnings: US$0.042 loss per share (vs US$0.16 loss in 3Q 2023)
Enzo Biochem shares are down 9.2% from a week ago. The company reported a loss of US$2.13m in the third quarter of 2024. The stock is down 10% from its highs in the last week. There are 3 warning signs for Enzo biochem.
Simply Wall St · 5d ago
Weekly Report: what happened at ENZ last week (0610-0614)?
Weekly Report · 06/17 09:25
Enzo Biochem (ENZ) Q3 Earnings Improve Y/Y, Gross Margin Up
NASDAQ · 06/14 17:18
ENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024
Enzo Biochem just reported results for the third quarter of 2024. The company reported earnings per share of -4 cents and revenue of $8.02 million. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports to help readers understand the figures.
Investorplace · 06/14 01:52
Enzo Biochem Non-GAAP EPS of -$0.03, revenue of $8.02M
Seeking Alpha · 06/13 20:52
Press Release: Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update
Dow Jones · 06/13 20:20
Press Release: Enzo Biochem Reports Third Quarter -2-
Dow Jones · 06/13 20:20
More
About ENZ
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research customers worldwide. The Company is engaged in product development and manufactures and supplies a comprehensive portfolio of products, including antibodies, genomic probes, assays, biochemicals and proteins. The Company's products and technologies are used in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry and small molecule chemistry. Its life science division supports the work of research centers and industry partners. It has built a portfolio of intellectual property assets, comprised of around 457 owned patents worldwide.

Webull offers Enzo Biochem Inc stock information, including NYSE: ENZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENZ stock methods without spending real money on the virtual paper trading platform.